Alpa Laboratories Hits 52-Week Low at Rs 91.00 Amid Market Volatility

Alpa Laboratories, a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a significant milestone by touching its 52-week low on October 3, 2025, with a new low price recorded at Rs 91.00. This decline comes amid a broader market context where the Nifty index has shown resilience, recovering from an initial drop to trade at 24,894.25, just 3.11% away from its own 52-week high.
Despite a recent two-day gain of 1.12%, Alpa Laboratories has struggled to maintain momentum, trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Over the past year, the stock has underperformed significantly, with a return of -31.53%, contrasting sharply with the Sensex's decline of only -1.56%.

The company's financial metrics reveal a mixed picture, with net sales growth at an annual rate of 6.05% and operating profit growth at 17.35% over the last five years. However, recent quarterly results showed net sales at Rs 19.11 crore, indicating flat performance. Alpa Laboratories continues to maintain a low debt-to-equity ratio and a reasonable price-to-book value, suggesting a stable financial position despite recent challenges.